Skip to content

BeiGene

US · ONC #538 by market cap Listed 2016
390.94 -8.76 -2.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About BeiGene

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Founded
2010
CEO
Mr. John V. Oyler
Employees
12,000
Headquarters
Basel, Basel-Landschaft (Basle Country), Switzerland
Fiscal year end
12-31
Website
beonemedicines.com

Company profile

Exchange
US
Symbol
ONC
Market-cap rank
#538
Listing date
2016-02-03
Market cap
44.66B
Float cap
31.65B
Shares out
114.23M
Float shares
80.95M

Sectors & themes

Biotechnology HK ADR Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

BeiGene discussion 0 comments

Add a comment